A Phase I Study to Evaluate LIFE-001
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Healthy Volunteers
In brief
The goal of this clinical trial is to learn if LIFE-001 is safe and tolerable for healthy adult volunteers.
Key facts
- Study ID
- NCT06904807
- Run by
- LifeMine Therapeutics
- People needed
- 160
- Starts
- 2025-04-07
- Expected to finish
- 2026-11-13
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Female or male between the ages of 18 and 65 years, inclusive
- Medically healthy (without significant medical issues, e.g. high blood pressure)
- Must provide written informed consent
You may not qualify if…
- Ongoing or history of any psychiatric, medical or surgical condition that might jeopardize the participant's safety or interfere with the absorption, distribution or excretion of the study drug
- Any abnormal ECG findings, laboratory value or physical examination findings
- Positive ethanol, drug screen or cotinine test
- Use of systemic prescription medications or over-the-counter (OTC) medication, including multivitamins, and dietary and herbal supplement within 7 days
- Use of any experimental or investigational device within 30 days
- Donation or loss of 500 mL or more of blood within 30 weeks and/or donation of plasma within 30 days
Where it is running
- Veritus Research Pty Ltd — Bayswater, Victoria, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.